Exact Sciences to Participate in March Investor Conference
Exact Sciences Corp. (EXAS) to participate in TD Cowen 44th Annual Health Care Conference with a fireside chat on March 4, 2024. Investors invited to join via webcast.
02/26/2024 - 06:00 AM
MADISON, Wis. --(BUSINESS WIRE)--
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.
TD Cowen 44th Annual Health Care Conference, Boston
The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com .
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com , follow Exact Sciences on X (formerly known as Twitter) @ExactSciences , or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226098675/en/
Nathan Harrill
investorrelations@exactsciences.com
Source: Exact Sciences Corp.
When is Exact Sciences Corp. participating in the TD Cowen 44th Annual Health Care Conference?
Exact Sciences Corp. (EXAS) is participating in the TD Cowen 44th Annual Health Care Conference on March 4, 2024.
What time is the fireside chat scheduled for during the conference?
The fireside chat is scheduled for 1:30 p.m. ET on March 4, 2024.
How can investors join the conference webcast?
Investors can access the webcast in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
EXAS Rankings
#234 Ranked by Stock Gains
EXAS Stock Data
Industry
Diagnostic Imaging Centers
Sector
Health Care and Social Assistance
Tags
Health Technology, Biotechnology
Country
US
City
Madison
About EXAS
exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences' noninvasive colon cancer screening test, visit cologuardtest.com
